The value of sPESI for risk stratification in patients with pulmonary embolism

IntroductionVarious risk stratification methods exist for patients with pulmonary embolism (PE). We used the simplified Pulmonary Embolism Severity Index (sPESI) as a risk-stratification method to understand the Veterans Health Administration (VHA) PE population.Materials and methodsAdult patients with 1 inpatient PE diagnosis (index date=discharge date) from October 2011-June 2015 as well as continuous enrollment for 12months pre- and 3months post-index date were included. We defined a sPESI score of 0 as low-risk (LRPE) and all others as high-risk (HRPE). Hospital-acquired complications (HACs) during the index hospitalization, 90-day follow-up PE-related outcomes, and health care utilization and costs were compared between HRPE and LRPE patients.ResultsOf 6746 PE patients, 95.4% were men, 67.7% were white, and 22.0% were African American; LRPE occurred in 28.4% and HRPE in 71.6%. Relative to HRPE patients, LRPE patients had lower Charlson Comorbidity Index scores (1.0 vs. 3.4, p<0.0001) and other baseline comorbidities, fewer HACs (11.4% vs. 20.0%, p<0.0001), less bacterial pneumonia (10.6% vs. 22.3%, p<0.0001), and shorter average inpatient lengths of stay (8.8 vs. 11.2days, p<0.0001) during the index hospitalization. During follow-up, LRPE patients had fewer PE-related outcomes of recurrent venous thromboembolism (4.4% vs. 6.0%, p=0.0077), major bleeding (1.2% vs. 1.9%, p=0.0382), and death (3.7% vs. 16.2%, p<0.0001). LRPE patients had fewer inpatient but higher outpatient visits per patient, and lower total health care costs ($12,021 vs. $16,911, p<0.0001) than HRPE patients.ConclusionsUsing the sPESI score identifies a PE cohort with a lower clinical and economic burden.